Its fourth quarter results are in the books and Haywood analyst Neal Gilmer has maintained his “Buy” rating on Rubicon ...

Following the company’s fourth quarter results, RBC analyst Paul Treiber has cut his price target on BlackBerry ...

Following the company’s fourth quarter results, National Bank Financial analyst Rupert Merer has downgraded Exro Technologies ...

Following the company’s most recent acquisition, Haywood analyst Neal Gilmer has maintained his “Buy” rating on Organigram.

HEALWELL AI has made an acquisition that will present the company with immediate upsell opportunities., says Raymond James ...

On March 31, in a research update to clients, Treiber maintained his “Hold” rating and price target of (US) $4.00 on BlackBerry. On April 2, BlackBerry reported its Q4 and fiscal 2024 results. In the ...

Delayed financials from WELL Health mean an opportunity for investors, says Ventum Capital Markets analyst Rob Goff.

TD Cowen analyst Vince Valentini says he is feeling more bullish about Quebecor, and has raised his price target on it.

Following the company’s fourth quarter results, Ventum Capital Markets analysts Andrew Semple has maintained his “Buy” rating ...

Following the company’s fourth quarter results, ATB Capital analyst Martin Toner has cut his price target on Bitfarms.

Ahead of the company’s fourth quarter results, CIBC analyst Todd Coupland has maintained his “Buy” rating and $7.00 price ...

Following the company’s fourth quarter results, Beacon analyst Russell Stanley has cut his price target on Cematrix.